Stockscreener 앱 받기
0.61
5.15%
0.0299
시장 영업 전:
.64
0.03
+4.92%
Vaxart Inc 주식(VXRT)의 최신 뉴스
Investors Give Vaxart, Inc. (NASDAQ:VXRT) Shares A 29% Hiding - Simply Wall St
Vaxart Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
Vaxart, Inc. Reports Third Quarter 2024 Financial Results – - Defense World
Vaxart, Inc. (NASDAQ:VXRT) Q3 2024 Earnings Call Transcript - Insider Monkey
Vaxart, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Earnings call: Vaxart reports progress in vaccine programs and financial growth - Investing.com
Vaxart Inc (NASDAQ: VXRT): Blank Check On Growth? - Stocks Register
Vaxart Inc (VXRT) Q3 2024 Earnings Call Highlights: Advancements in Oral Vaccine Platform and Financial Growth - GuruFocus.com
Vaxart Inc (VXRT) Q3 2024 Earnings Call Highlights: Advancements in Oral Vaccine Platform and ... - Yahoo Finance
Vaxart Inc reports results for the quarter ended September 30Earnings Summary - XM
Vaxart’s Q3 2024: Progress in Oral Vaccine Development - TipRanks
VAXART, INC. (VXRT) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
Vaxart's Q3 Revenue Jumps 133% to $4.9M, Narrows Losses Amid COVID Trial Progress | VXRT Stock News - StockTitan
Vaxart Provides Business Update and Reports Third Quarter 2024 Financial Results - Yahoo Finance
Vaxart (VXRT) Scheduled to Post Earnings on Wednesday - MarketBeat
Vaxart to Host Third Quarter 2024 Business Update and Financial Results Conference Call on November 13 - The Manila Times
Vaxart (VXRT) Sets Q3 2024 Earnings Call for November 13: Key Updates Coming | VXRT Stock News - StockTitan
While shareholders of Vaxart (NASDAQ:VXRT) are in the black over 5 years, those who bought a week ago aren't so fortunate - Simply Wall St
Vaxart (NASDAQ:VXRT) Stock Price Passes Below Two Hundred Day Moving AverageTime to Sell? - MarketBeat
Investing in Vaxart (NASDAQ:VXRT) five years ago would have delivered you a 127% gain - Yahoo Finance
VXRTVaxart, Inc Latest Stock News & Market Updates - StockTitan
Vaxart (NASDAQ:VXRT) Shares Cross Below 200 Day Moving AverageShould You Sell? - MarketBeat
Vaxart to Showcase its COVID-19 and Norovirus Oral Pill Vaccine Candidates at World Vaccine Congress Europe 2024 - StockTitan
Millennium Management LLC Has $2.66 Million Stock Holdings in Vaxart, Inc. (NASDAQ:VXRT) - MarketBeat
Check out these key findings about Vaxart Inc (VXRT) - SETE News
Vaxart to Present Norovirus Data at IDWeek 2024 Underscoring Commitment to Address Significant Unmet Need - StockTitan
VXRT stock rated an Outperform by Oppenheimer - Knox Daily
Did Vaxart Inc (VXRT) perform well in the last session? - US Post News
Best Penny Stocks Under $1 To Buy Now - AOL
Vaxart Inc (VXRT) Q2 2024 Earnings Call Highlights: Revenue Surge and Strategic Advances - Yahoo Finance
Vaxart ends agreement with sales agents, halts stock sales By Investing.com - Investing.com Australia
Vaxart, Inc. Terminates Controlled Equity Offering Sales Agreement with Sales Agents - MarketBeat
Vaxart ends agreement with sales agents, halts stock sales - Investing.com India
Vaxart Ends Sales Agreement, Halts Stock Offering - TipRanks
The growth track for Vaxart Inc (VXRT) has changed recently - SETE News
Vaxart (NASDAQ:VXRT) Stock Crosses Below 200 Day Moving AverageHere's What Happened - MarketBeat
Vaxart Inc (VXRT) Stock: A Year of Declines and Increases - The InvestChronicle
Vaxart Inc [VXRT] Shares Rise 4.78 % on Wednesday - Knox Daily
Vaxart Initiates Phase 2b Study of Oral COVID-19 Vaccine - Contagionlive.com
It makes sense and dollars to buy Vaxart Inc (VXRT) stock - SETE News
Dr. Wouter Latour Joins PharmaJet as Chief Executive Officer - BioSpace
Vaxart Announces Initiation of Sentinel Cohort for Phase 2b Study Evaluating Its COVID-19 Oral Pill Vaccine - EIN News
Vaxart Announces Initiation of Sentinel Cohort for Phase 2b Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate - StockTitan
Vaxart (NASDAQ:VXRT) Shares Pass Above 200-Day Moving Average of $0.84 - MarketBeat
The Sherwin-Williams Company (NYSE:SHW) Shares Sold by Kingfisher Capital LLC - Defense World
Does Vaxart Inc (VXRT) offer a good opportunity for investors? - SETE News
Stocks to Watch Tuesday: Visa, Deere, Baidu, Alibaba, Smartsheet - The Wall Street Journal
Vaxart Inc (VXRT)’s stock rises to 0.84 per share - US Post News
YUM CHINA Largest Self-built Supply Chain Center Put into Operation in Jiading, Shanghai - AASTOCKS.com
Upward Trajectory: Vaxart Inc (VXRT) Posts a Slidee, Closing at 0.83 - The Dwinnex
Cathay Cargo and Menzies agree south-west Pacific contract renewal - Aviation Business News
J.W. Cole Advisors Inc. Boosts Stock Holdings in The Sherwin-Williams Company (NYSE:SHW) - Defense World
Vaxart (NASDAQ:VXRT) Shares Cross Above 200-Day Moving Average of $0.85 - MarketBeat
VXRT (Vaxart Inc) may reap gains as insiders became active recently - Knox Daily
Financial Snapshot: Analyzing Vaxart Inc (VXRT)’s Key Ratio Metrics - The Dwinnex
Is Vaxart Inc (VXRT) a good investment opportunity? - US Post News
Goldman Thinks Walgreens Boots Alliance, Inc. (WBA) Is A Long-Term AI Stock Set To Rally Eventually - Insider Monkey
Moderna’s spending cuts, pipeline shakeup leave doubts about a rebound, analysts say - MSN
Investing in Vaxart Inc (VXRT) Is Getting More Attractive - Knox Daily
Monaco Asset Management SAM Invests $402,000 in Vaxart, Inc. (NASDAQ:VXRT) - MarketBeat
3.66%
1.11%
자본화:
|
볼륨(24시간):